KOODAC
Meet KOODAC, whose aim is to develop orally bioavailable drugs that will dramatically improve cure rates for children affected by these cancers.
Meet the five new global teams below, who have been selected to receive up to $25m each over five years to come together and think differently to drive progress against cancer. This $125m investment marks Cancer Grand Challenges' largest funding round to date.
Cancer Grand Challenges brings together diverse international organisations, collaborators and research leaders who share its mission: the Scientific Foundation of the Spanish Association Against Cancer, the Bowelbabe Fund for Cancer Research UK, Institut National Du Cancer, The Mark Foundation for Cancer Research and KiKa (Children Cancer Free Foundation).
We’re delighted to welcome these new teams to our growing global community, now at 1,200+ investigators and collaborators across 16 countries and taking on 13 challenges.
For press enquiries, please contact Rachel Cresswell at rachel.cresswell@cancergrandchallenges.org
For general enquiries, please contact info@cancergrandchallenges.org